Autocrine Mechanisms of Angiogenesis
Autocrine Mechanisms of Angiogenesis
批准号:
7066034
负责人:
Paolo Mignatti
金额:
$37.96万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-06-30
关键词:
angiogenesisapoptosisautocrinebiological signal transductioncapillarycell differentiationflow cytometrygrowth factor receptorshigh performance liquid chromatographyimmunocytochemistryintermolecular interactionlaboratory mouseterminal nick end labelingtransforming growth factorsvascular endothelial growth factorsvascular endothelium
中文摘要
描述(由申请人提供):我们广泛的初步工作产生了意想不到的假设,即转化生长因子-β 1(TGF-β 1)对内皮细胞的成熟凋亡作用是由内源性血管内皮生长因子(VEGF)介导的。这一结论是基于我们的发现,TGF-β 1刺激血管内皮细胞表达VEGF和VEGF的单克隆抗体阻断TGF-β 1诱导的细胞凋亡。由于细胞凋亡是血管形成的一个重要组成部分,这种新的内皮细胞凋亡机制可能在血管生成和血管发生中发挥重要作用。因此,我们建议:1.表征内源性VEGF介导TGF-β 1对内皮细胞的凋亡活性的VEGF受体和下游信号通路。我们将研究内源性VEGF激活的信号转导通路,以响应TGF-β 1治疗,以及VEGF和TGF-β 1特异性通路之间的潜在串扰。合成抑制剂和显性失活突变体的使用将提供介导TGF-β 1凋亡信号的信号传导途径的鉴定。2.研究VEGF介导的细胞凋亡在体内外血管生成中的作用。TGF-β 1诱导细胞凋亡和血管形成。基于我们的初步工作,我们假设TGF-β 1的血管生成和血管生成活性是由VEGF介导的自分泌机制。我们建议使用血管生成和血管生成的体外和体内模型来测试我们的假设。结果将阐明血管形成是由VEGF和TGF-β 1,两个有效的血管生成诱导剂的相互作用控制的机制。详细了解VEGF和TGF-β 1相互作用的机制,对于开发旨在控制血管生成的药物治疗具有重要意义。
英文摘要
DESCRIPTION (provided by applicant): Our extensive preliminary work has generated the unexpected hypothesis that the well-established apoptotic effect of transforming growth factor-beta 1 (TGF-b1) on endothelial cells is mediated by endogenous vascular endothelial growth factor (VEGF). This conclusion is based on our findings that TGF-b1 stimulates endothelial cell expression of VEGF and that monoclonal antibodies to VEGF block TGF-b1-induced apoptosis. Because apoptosis is an essential component of vessel formation, this novel mechanism of endothelial cell apoptosis may have an important role in angiogenesis and vasculogenesis. We therefore propose: 1. To characterize the VEGF receptor(s) and downstream signaling pathways through which endogenous VEGF mediates the apoptotic activity of TGF-b1 on endothelial cells. We will investigate signal transduction pathways activated by endogenous VEGF in response to TGF-b1 treatment, and potential cross-talk between VEGF- and TGF-b1-specific pathways. The use of synthetic inhibitors and dominant negative mutants will afford the identification of the signaling pathway(s) that mediate TGF-b1 apoptotic signal(s). 2. To study the role of VEGF-mediated apoptosis in angiogenesis and vasculogenesis in vitro and in vivo. TGF-b1 induces both apoptosis and vessel formation. Based on our preliminary work, we hypothesize that the angiogenic and vasculogenic activities of TGF-b1 are mediated by VEGF with an autocrine mechanism. We propose to test our hypothesis using in vitro and in vivo models of angiogenesis and vasculogenesis. The results will elucidate the mechanisms through which vessel formation is controlled by the interplay of VEGF and TGF-b1, two potent angiogenesis inducers. A detailed understanding of the mechanisms through which VEGF and TGF-b1 interact can have important implications for the development of pharmacological treatments aimed at the control of angiogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of MT1-MMP proteolytic activity in osteogenesis
-
批准号:9386911
-
项目类别:
-
资助金额:$22.37万
-
财政年份:2017
-
负责人:Paolo Mignatti
-
依托单位:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
-
批准号:8768508
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2013
-
负责人:Paolo Mignatti
-
依托单位:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
-
批准号:8403629
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2009
-
负责人:Paolo Mignatti
-
依托单位:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
-
批准号:8141806
-
项目类别:
-
资助金额:$3.17万
-
财政年份:2009
-
负责人:Paolo Mignatti
-
依托单位:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
-
批准号:8034818
-
项目类别:
-
资助金额:$34.12万
-
财政年份:2009
-
负责人:Paolo Mignatti
-
依托单位:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
-
批准号:8204871
-
项目类别:
-
资助金额:$34.12万
-
财政年份:2009
-
负责人:Paolo Mignatti
-
依托单位:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
-
批准号:7655070
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2009
-
负责人:Paolo Mignatti
-
依托单位:
Physiological role of MT1-MMP-mediated, proteolysis-independent signaling in vivo
-
批准号:8264303
-
项目类别:
-
资助金额:$3.38万
-
财政年份:2009
-
负责人:Paolo Mignatti
-
依托单位:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
-
批准号:7941654
-
项目类别:
-
资助金额:$13.83万
-
财政年份:2009
-
负责人:Paolo Mignatti
-
依托单位:
Physiological role of MT1-MMP-mediated, proteolysis-independent signaling in vivo
-
批准号:7769518
-
项目类别:
-
资助金额:$20.64万
-
财政年份:2009
-
负责人:Paolo Mignatti
-
依托单位:
NON-PROTEOLYTIC INTERACTIONS OF TIMP-2 AND MT1-MMP
-
批准号:8210232
-
项目类别:
-
资助金额:$6.68万
-
财政年份:2009
-
负责人:Paolo Mignatti
-
依托单位:
Autocrine Mechanisms of Angiogenesis
-
批准号:7119315
-
项目类别:
-
资助金额:$4.34万
-
财政年份:2003
-
负责人:Paolo Mignatti
-
依托单位:
Autocrine Mechanisms of Angiogenesis
-
批准号:7477457
-
项目类别:
-
资助金额:$6.31万
-
财政年份:2003
-
负责人:Paolo Mignatti
-
依托单位:
Autocrine Mechanisms of Angiogenesis
-
批准号:6766874
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2003
-
负责人:Paolo Mignatti
-
依托单位:
Autocrine Mechanisms of Angiogenesis
-
批准号:6895194
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2003
-
负责人:Paolo Mignatti
-
依托单位:
Autocrine Mechanisms of Angiogenesis
-
批准号:6580957
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2003
-
负责人:Paolo Mignatti
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: